Strand AI
Multimodal foundation models to predict uncollected patient biology
Acerca de
Descripción de la empresa en inglés
Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
Temas
HealthcareDrug Discovery and Delivery
- Ubicación
- San Francisco, CA, Estados Unidos
- Equipo
- 2 empleados
- Promoción de YC
- Winter 2026
- Estado
- Activa
- Etapa
- Etapa temprana
